Company Filing History:
Years Active: 2015
Title: Duen-Cheng Wang: Innovator in Bone Implantation Technology
Introduction
Duen-Cheng Wang is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of biomedical engineering, particularly in the area of bone implantation technology. His innovative work has the potential to improve patient outcomes in orthopedic procedures.
Latest Patents
Duen-Cheng Wang holds a patent for a composite of amorphous calcium phosphate/calcium sulfate hemihydrate (CSH/ACP) designed for bone implantation. The patent describes a composite comprising α-calcium sulfate (CS) hemihydrate and amorphous calcium phosphate (α-CSH/ACP) in a weight ratio ranging from about 10:90 to about 90:10. This composite is notable for its resorption period of 3-6 months, making it a valuable option for bone healing. Additionally, the invention includes a one-pot process for producing the α-CSH/ACP composite, allowing for efficient synthesis in a single step.
Career Highlights
Duen-Cheng Wang is affiliated with Taipei Medical University, where he continues to advance research in his field. His work has garnered attention for its practical applications in medicine, particularly in enhancing the effectiveness of bone implants.
Collaborations
He has collaborated with esteemed colleagues such as Jen-Chang Yang and Sheng-Yang Lee, contributing to a dynamic research environment that fosters innovation and development in biomedical technologies.
Conclusion
Duen-Cheng Wang's contributions to the field of bone implantation technology exemplify the impact of innovative research on healthcare. His patented composite and production process represent significant advancements that could lead to improved surgical outcomes for patients.